Search results
Results from the WOW.Com Content Network
Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware, [2] is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular ...
[6] [7] The first AUS model on the market was the AMS 800 (Boston Scientific, Marlborough, MA), developed 50 years ago. [8] [9] It is a 3-component device with a cuff placed around the urethra, a pump inserted in the scrotum and a pressure generating reservoir placed in the pelvis, which comes as a kit to prepare and to fill up before ...
An investigation showed that Boston's device, Obsidio Embolic, when used with a specific technique posed a higher risk of bowel ischemia during procedures to stop gastrointestinal (GI) bleeding ...
Boston Scientific's device, which it plans to launch in the coming months, is a balloon catheter coated with a drug called paclitaxel and is designed to transfer the drug to the vessel wall to ...
Navilyst Medical was founded in February 2008 out of the $425 million Avista Capital Partners acquisition of Boston Scientific's Fluid Management and Vascular Access division. The acquisition was seen as a way to focus on "opportunities it sees with vein-access devices, instead of competing for resources with many other projects inside the ...
Boston Scientific forecast a full-year profit on Wednesday that was largely ahead of analysts' estimates and said the U.S. health regulator has approved its heart device, sending the company's ...
The next day, Boston Scientific increased their bid to $25 billion, followed the next day by Johnson & Johnson increasing their bid to $24.2 billion. It was not until January 17 that Boston Scientific produced a new offer of $27.2 billion ($80 per share), with the help of Abbott Laboratories. Abbott agreed to purchase $1.4 billion of Boston ...
Biocompatibles International plc was a medical technology company in the field of drug-device combination products. It was acquired by BTG plc in 2010, [2] which was, in turn, acquired by Boston Scientific in 2019. [3] [4] Approved oncology products were supplied and marketed from facilities in Farnham, Surrey, UK and Oxford, Connecticut.